FDA Tightens Guidelines on Technique for Uterine Fibroid Surgery

Share this content:
FDA tightens guidelines on technique for uterine fibroid surgery
FDA tightens guidelines on technique for uterine fibroid surgery
The agency said on Monday it is recommending that a boxed warning be placed on laparoscopic power morcellator devices used to treat uterine fibroids. Such an FDA warning is the strongest that a medication or treatment can carry while still remaining on the U.S. The devices are used to slice fibroid and uterine tissue into small pieces inside the body, allowing it to be removed through a small opening.
READ FULL ARTICLE From Reuters
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »